Huashan Hong

1.1k total citations
31 papers, 789 citations indexed

About

Huashan Hong is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Huashan Hong has authored 31 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Huashan Hong's work include Cardiovascular Function and Risk Factors (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Heart Failure Treatment and Management (3 papers). Huashan Hong is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Heart Failure Treatment and Management (3 papers). Huashan Hong collaborates with scholars based in China, United States and Australia. Huashan Hong's co-authors include Yilang Ke, Xiaoyun Shi, Lemin Zheng, Bing Pan, Changjie Liu, Si Cheng, Li Dang, Aiping Zeng, Mingming Zhao and Jia Liu and has published in prestigious journals such as Free Radical Biology and Medicine, Arteriosclerosis Thrombosis and Vascular Biology and Advanced Science.

In The Last Decade

Huashan Hong

30 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huashan Hong China 13 403 248 174 123 80 31 789
Si Cheng China 11 439 1.1× 306 1.2× 88 0.5× 125 1.0× 54 0.7× 34 830
Melanie C. Zigler United States 10 422 1.0× 428 1.7× 249 1.4× 59 0.5× 51 0.6× 20 966
Lauren M. Cuevas United States 6 330 0.8× 254 1.0× 184 1.1× 33 0.3× 35 0.4× 10 696
Yilang Ke China 8 334 0.8× 222 0.9× 51 0.3× 116 0.9× 33 0.4× 14 547
Changmeng Cui China 17 342 0.8× 82 0.3× 70 0.4× 71 0.6× 44 0.6× 36 931
Saifudeen Ismael United States 16 675 1.7× 173 0.7× 59 0.3× 106 0.9× 78 1.0× 39 1.1k
Santiago Cuevas United States 17 405 1.0× 87 0.4× 134 0.8× 49 0.4× 71 0.9× 40 819
Daniel W. Trott United States 15 243 0.6× 362 1.5× 293 1.7× 32 0.3× 71 0.9× 29 1.2k
Jianping Tao China 11 212 0.5× 70 0.3× 94 0.5× 66 0.5× 131 1.6× 25 763
Lawrence C. Johnson United States 11 186 0.5× 261 1.1× 156 0.9× 31 0.3× 31 0.4× 20 653

Countries citing papers authored by Huashan Hong

Since Specialization
Citations

This map shows the geographic impact of Huashan Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huashan Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huashan Hong more than expected).

Fields of papers citing papers by Huashan Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huashan Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huashan Hong. The network helps show where Huashan Hong may publish in the future.

Co-authorship network of co-authors of Huashan Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Huashan Hong. A scholar is included among the top collaborators of Huashan Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huashan Hong. Huashan Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Wenhui, et al.. (2025). Gut microbiota remodelling alleviates elderly sepsis by microbiota-derived acetic acid via FFAR2/NLRP3 pathway. European Journal of Pharmacology. 1007. 178229–178229.
2.
Xie, Wenhui, et al.. (2024). Influencing and Prognostic Factors of End-Stage Hypertrophic Cardiomyopathy. ESC Heart Failure. 11(6). 4028–4037. 1 indexed citations
3.
Ke, Yilang, et al.. (2024). Loss of Endothelial Annexin A1 Aggravates Inflammation‐Induched Vascular Aging. Advanced Science. 11(15). e2307040–e2307040. 14 indexed citations
4.
Lin, Nan, et al.. (2024). The Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Novel Predictor of the Prevalence of Senile Osteoporosis. Clinical Interventions in Aging. Volume 19. 1773–1788. 1 indexed citations
5.
Wang, Zhuolin, Jun Fang, & Huashan Hong. (2023). Evaluation the value of H2FPEF score and HFA-PEFF step E score in the diagnosis of heart failure with preserved ejection fraction. Acta cardiologica. Supplementum. 78(7). 790–795. 2 indexed citations
6.
Zhang, Qi, Yilang Ke, & Huashan Hong. (2022). HDL and Lipid Metabolism. Advances in experimental medicine and biology. 1377. 49–61. 9 indexed citations
7.
Li, Qingqing, Wenhui Xie, Liping Li, et al.. (2021). Development and Validation of a Prediction Model for Elevated Arterial Stiffness in Chinese Patients With Diabetes Using Machine Learning. Frontiers in Physiology. 12. 714195–714195. 8 indexed citations
9.
Hu, Danqing, Guilin Chen, Huashan Hong, et al.. (2021). Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction. Cell Death and Disease. 12(6). 505–505. 17 indexed citations
10.
Fang, Jun, Ying Teng, Huashan Hong, et al.. (2020). Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia–Reperfusion Injury by Inhibiting the p‐JNK/Caspase‐3 Signaling Pathway in Rat Microvascular Pericytes. Journal of the American Heart Association. 9(13). e016047–e016047. 18 indexed citations
13.
Ke, Yilang, Li Dang, Mingming Zhao, et al.. (2018). Gut flora-dependent metabolite Trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress. Free Radical Biology and Medicine. 116. 88–100. 218 indexed citations
14.
Hong, Huashan, et al.. (2015). Upregulation of TRPC1/6 may be involved in arterial remodeling in rat. Journal of Surgical Research. 195(1). 334–343. 15 indexed citations
15.
Hong, Huashan. (2011). New advances of renal natriuretic peptide system. 1 indexed citations
16.
Li, Jiabin & Huashan Hong. (2011). [The value of aggressive diuretic therapy in acute decompensated stage of chronic heart failure].. PubMed. 23(6). 359–62. 1 indexed citations
17.
18.
Zhu, Junren, Ningling Sun, Kan Yang, et al.. (2011). Efficacy and safety of aliskiren, a direct renin inhibitor, compared with ramipril in Asian patients with mild to moderate hypertension. Hypertension Research. 35(1). 28–33. 14 indexed citations
19.
Hong, Huashan. (2006). Relationship between hypertension and inflammation. Zhongguo linchuang yaolixue yu zhiliaoxue. 1 indexed citations
20.
Wu, Duojiao, Huashan Hong, & Qiong Jiang. (2005). [Effect of shexiang baoxin pill in alleviating myocardial fibrosis in spontaneous hypertensive rats].. PubMed. 25(4). 350–3. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026